Skip to main content
. Author manuscript; available in PMC: 2013 Nov 13.
Published in final edited form as: J Clin Cell Immunol. 2011 Nov 15;Suppl 1:003. doi: 10.4172/2155-9899.S1-003

Figure 5. PI-3-K/Akt (PKB) are upstream of calpastatin/calpain.

Figure 5

(A) Eosinophils were left untreated, or treated as shown for 72h. Cell viability was determined by FACS and presented as a percentage of viability at time 0. **, P< 0.01 (one-way ANOVA). (B) Immunoblot for calpain-1 and calpastatin after 20 hr incubation under the conditions shown. All blots are representative of at least 3 independent experiments with different donors and data are expressed as the mean ± SEM.